Anticancer Therapies – Products

Poly (ADP-ribose) polymerases (PARP) transfer ADP-ribose to itself and other nuclear proteins such as histones, therefore PARP play a crucial role in regulating DNA repair. A luminescent cellular PARP assay and a fluorescent cell viability assay were performed on BMG LABTECH’s FLUOstar Omega to evaluate PARP inhibitors. PARP inhibition has been demonstrated to potentiate the cytotoxicity of anti-cancer drugs and ionising radiation. The ability of the FLUOstar Omega to measure absorbance, lumines

The new kits are optimized for characterization of proteins in the MEK and ERK families on the Firefly™ 3000 Protein Analysis System.

The DMET™ Plus Premier Pack features a comprehensive panel of known pharmacogenetic drug metabolism markers.

Bigneat recently completed installation of a LABS biological safety enclosure for Cancer Research at the Queen Alexandra Hospital in UK.

BioWindows™ is designed for individuals to compile personalized in-depth profiles to help determine the most appropriate medical solution.

This week AnaSpec has introduced 50 new catalog peptides and one new fluorescent dye.

Promega has announced the launch of the CytoTox-Glo™ Cytotoxicity Assay at the 5th annual Screening Europe conference and exhibition.

The Company says that fast SYBR Green® Master Mix is designed to perform fast real-time PCR experiments while maintaining high quality data.

Biolog expands its PM product line to enable nearly 1,500 simultaneous phenotypic assays of human and other mammalian cells.

The addition of this technology to the MISSION® shRNA platform pairs the benefits of lentiviral-based shRNA with a simple streamlined protocol.